Theradiag SA

ENXTPA:ALTER Stock Report

Market Cap: €16.4m

Theradiag Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Simon Daviere

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Oct 04
Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Oct 03
Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Theradiag (EPA:ALTER) Is Carrying A Fair Bit Of Debt

Oct 26
Theradiag (EPA:ALTER) Is Carrying A Fair Bit Of Debt

CEO

Simon Daviere (39 yo)

less than a year

Tenure

Mr. Simon Davière is Chief Executive Officer of Theradiag SA from March 01, 2023 and also serves as its General Manager since 2023. He holds an engineering degree in Biological Engineering from the Univers...

Board Members

NamePositionTenureCompensationOwnership
Christian Policard
Independent Chairmanless than a yearno datano data
Larry Abensur
Director1.6yrsno datano data
Thierry Paper
Director1.6yrsno datano data
Jacques Azancot
Independent Director1.5yrsno datano data

1.5yrs

Average Tenure

Experienced Board: ALTER's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.